IP Library Granted Patent US 10,286,227
Granted Patent B2
US 10,286,227 · App. 15/594,905 · Granted May 14, 2019

Radioactive therapeutic device with fixation

Inventors: John J. Munro, III (North Andover, MA); Matthew R. Hollows (Westminster, MA)
Assignee: Spec Med Intellectual Property, LLC
A61N5/1007A61N2005/1011A61N2005/1024Y10T29/49826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,286,227
App. No.
15/594,905
Granted
May 14, 2019
Kind
B2
Abstract

Devices and techniques for permanent application of radioactive sources in the field of brachytherapy are described. In an embodiment, an implantable device for radiation therapy of pathological tissues directed toward the administration of radiation to tissue adjacent a cavity wall or surgical excision. The device may include an insertable member, such as a substantially cylindrical member, having at least two ends, a central section positioned between the ends, and a fixation element to retain the implantable device implanted in tissue at a desired position. The device may further include a radioactive source at least partially positioned within the insertable member and that is disposed to deliver radiation to a desired area.

Claims (27)

1. An implantable device for brachytherapy, comprising:

an insertable member having a first end and a second end, a central section positioned between the ends, and a fixation element having at least one barbed protrusion that resists removal through an aperture created by deployment to retain the implantable device in an inserted position within tissue; and

a radioactive source disposed within the insertable member, wherein the insertable member is made of a memory alloy, and wherein the fixation element includes a non-straight configuration into which the insertable member forms after insertion into the inserted position and wherein the radioactive source is encapsulated within the fixation element.

2. The implantable device according to claim 1 , wherein the memory alloy is Nickel Titanium or nitinol.

3. The implantable device according to claim 1 , wherein the fixation element includes a plurality of barbed protrusions on the insertable member.

4. The implantable device according to claim 1 , wherein the radioactive source is encapsulated within the insertable member.

5. The implantable device according to claim 4 , wherein the radioactive source is completely encapsulated within the insertable member.

6. The implantable device according to claim 4 , wherein the insertable member includes a chamber with at least one cut-out for external accessibility, and wherein the radioactive source is partially encapsulated within the insertable member by being disposed within the chamber with the at least one cut-out.

7. The implantable device according to claim 1 , wherein the radioactive source includes a radioactive nuclide selected from at least one of: palladium-103, iodine-125, gadolinium-153, samarium-145, cesium-131 or ytterbium-169.

8. The implantable device according to claim 1 , wherein the insertable member includes at least one of: a bio-resorbable component or a drug eluting component.

9. A method of manufacturing an implantable device for brachytherapy, comprising:

forming an insertable member of the implantable device for insertion into an area of tissue;

encapsulating a radioactive source in the implantable device; and

incorporating a fixation element having at least one barbed protrusion that resists removal through an aperture created by deployment to retain the implantable device in an inserted position within tissue, wherein the insertable member is made of a memory alloy and wherein the fixation element includes a non-straight configuration into which the insertable member forms after insertion into the inserted position and wherein the radioactive source is encapsulated within the fixation element.

10. The method according to claim 9 , wherein the radioactive source is completely encapsulated in the fixation element.

11. The method according to claim 9 , wherein the memory alloy is Nickel Titanium or nitinol.

12. The method according to claim 9 , wherein the radioactive source includes a radioactive nuclide selected from at least one of: palladium-103, iodine-125, gadolinium-153, samarium-145, cesium-131 or ytterbium-169.

13. The method according to claim 9 , wherein the insertable member includes at least one of: a bio-resorbable component or a drug eluting component.

14. A method for performing brachytherapy, comprising:

identifying an area of tissue for brachytherapy;

inserting an implantable device into the area of the tissue, wherein the implantable device includes a radioactive source encapsulated within the implantable device and a fixation element having at least one barbed protrusion that resists removal through an aperture created by deployment to retain the implantable device in an inserted position within tissue; and

fixedly disposing the implantable device using the fixation element to deliver radiation therapy to an area of the tissue, wherein the implantable device is made of a memory alloy and wherein the fixation element includes a non-straight configuration into which the implantable device forms after insertion into the inserted position and wherein the radioactive source is encapsulated within the fixation element.

15. The method according to claim 14 , wherein the memory alloy is Nickel Titanium or nitinol.

16. The method according to claim 14 , wherein the fixation element includes a plurality of barbed protrusions on the insertable member.

17. The method according to claim 14 , wherein the insertable member includes a chamber with at least one cut-out for external accessibility, and wherein the radioactive source is partially encapsulated within the fixation element by being disposed within the chamber with the at least one cut-out.

18. The method according to claim 14 , wherein the radioactive source includes a radioactive nuclide selected from at least one of: palladium-103, iodine-125, gadolinium-153, samarium-145, cesium-131 or ytterbium-169.

19. The method according to claim 14 , wherein the insertable member includes at least one of: a bio-resorbable component or a drug eluting component.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2024
From: SOURCE PRODUCTION AND EQUIPMENT COMPANY, INC.
To: SPEC150, LLC
Reel/Frame 067305/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2017
From: MUNRO, JOHN J., III; HOLLOWS, MATTHEW R.
To: SPEC MED INTELLECTUAL PROPERTY, LLC
Reel/Frame 042377/0357 →
Continuity (3)
Continuation 14308072 · Jun 18, 2014
Provisional Application 61837409 · Jun 20, 2013
Related Publication 20170246476A1 · Aug 31, 2017
Cited By (2)
US 12,268,894 US 12,296,190